AAAAAA

   
Results: 1-10 |
Results: 10
SYNTHESIS AND EVALUATION OF PEPTIDYL MICHAEL ACCEPTORS THAT INACTIVATE HUMAN RHINOVIRUS 3C PROTEASE AND INHIBIT VIRUS-REPLICATION
Authors: KONG JS VENKATRAMAN S FURNESS K NIMKAR S SHEPHERD TA WANG QM AUBE J HANZLIK RP
Citation: Js. Kong et al., SYNTHESIS AND EVALUATION OF PEPTIDYL MICHAEL ACCEPTORS THAT INACTIVATE HUMAN RHINOVIRUS 3C PROTEASE AND INHIBIT VIRUS-REPLICATION, Journal of medicinal chemistry, 41(14), 1998, pp. 2579-2587
DEVELOPMENT OF IN-VITRO PEPTIDE-SUBSTRATES FOR HUMAN RHINOVIRUS-14 2APROTEASE
Authors: WANG QM JOHNSON RB SOMMERGRUBER W SHEPHERD TA
Citation: Qm. Wang et al., DEVELOPMENT OF IN-VITRO PEPTIDE-SUBSTRATES FOR HUMAN RHINOVIRUS-14 2APROTEASE, Archives of biochemistry and biophysics (Print), 356(1), 1998, pp. 12-18
SMALL PEPTIDIC ALDEHYDE INHIBITORS OF HUMAN RHINOVIRUS 3C PROTEASE
Authors: SHEPHERD TA COX GA MCKINNEY E TANG J WAKULCHIK M ZIMMERMAN RE VILLARREAL EC
Citation: Ta. Shepherd et al., SMALL PEPTIDIC ALDEHYDE INHIBITORS OF HUMAN RHINOVIRUS 3C PROTEASE, Bioorganic & medicinal chemistry letters, 6(23), 1996, pp. 2893-2896
POTENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS THAT UTILIZE NONCODED D-AMINO ACIDS AS P-2 P-3 LIGANDS/
Authors: JUNGHEIM LN SHEPHERD TA BAXTER AJ BURGESS J HATCH SD LUBBEHUSEN P WISKERCHEN M MUESING MA
Citation: Ln. Jungheim et al., POTENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS THAT UTILIZE NONCODED D-AMINO ACIDS AS P-2 P-3 LIGANDS/, Journal of medicinal chemistry, 39(1), 1996, pp. 96-108
SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - PRECLINICAL INVESTIGATION OF THE EFFICACY AND TOXICITY OF DOXORUBICIN DELIVERED BY ANTIBODY-DIRECTED CATALYSIS
Authors: MEYER DL LAW KL PAYNE JK MIKOLAJCZYK SD ZARRINMAYEH H JUNGHEIM LN KING JK SHEPHERD TA STARLING JJ
Citation: Dl. Meyer et al., SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - PRECLINICAL INVESTIGATION OF THE EFFICACY AND TOXICITY OF DOXORUBICIN DELIVERED BY ANTIBODY-DIRECTED CATALYSIS, Bioconjugate chemistry, 6(4), 1995, pp. 440-446
SYNTHESIS AND PHARMACOKINETICS OF POTENT CARBAMATE HIV-1 PROTEASE INHIBITORS CONTAINING NOVEL HIGH-AFFINITY HYDROXYETHYLAMINE ISOSTERES
Authors: HORNBACK WJ MUNROE JE SHEPHERD TA HATCH SD MUESING MA WISKERCHEN MA COLACINO JM BAXTER AJ SU KS CAMPANALE KM
Citation: Wj. Hornback et al., SYNTHESIS AND PHARMACOKINETICS OF POTENT CARBAMATE HIV-1 PROTEASE INHIBITORS CONTAINING NOVEL HIGH-AFFINITY HYDROXYETHYLAMINE ISOSTERES, Bioorganic & medicinal chemistry letters, 5(23), 1995, pp. 2891-2896
POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS CONTAINING NONCODED D-AMINO ACIDS
Authors: MUNROE JE SHEPHERD TA JUNGHEIM LN HORNBACK WJ HATCH SD MUESING MA WISKERCHEN MA SU KS CAMPANALE KM BAXTER AJ COLACINO JM
Citation: Je. Munroe et al., POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS CONTAINING NONCODED D-AMINO ACIDS, Bioorganic & medicinal chemistry letters, 5(23), 1995, pp. 2897-2902
D-AMINO ACIDS AS NOVEL P-2 P-3 LIGANDS FOR INHIBITORS OF HIV-1 PROTEASE/
Authors: SHEPHERD TA JUNGHEIM LN BAXTER AJ
Citation: Ta. Shepherd et al., D-AMINO ACIDS AS NOVEL P-2 P-3 LIGANDS FOR INHIBITORS OF HIV-1 PROTEASE/, Bioorganic & medicinal chemistry letters, 4(11), 1994, pp. 1391-1396
DESIGN OF ANTITUMOR PRODRUGS - SUBSTRATES FOR ANTIBODY-TARGETED ENZYMES
Authors: JUNGHEIM LN SHEPHERD TA
Citation: Ln. Jungheim et Ta. Shepherd, DESIGN OF ANTITUMOR PRODRUGS - SUBSTRATES FOR ANTIBODY-TARGETED ENZYMES, Chemical reviews, 94(6), 1994, pp. 1553-1566
SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - REGRESSION AND LONG-TERM GROWTH-INHIBITION OF HUMAN COLON-CARCINOMA XENOGRAFT MODELS
Authors: MEYER DL JUNGHEIM LN LAW KL MIKOLAJCZYK SD SHEPHERD TA MACKENSEN DG BRIGGS SL STARLING JJ
Citation: Dl. Meyer et al., SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - REGRESSION AND LONG-TERM GROWTH-INHIBITION OF HUMAN COLON-CARCINOMA XENOGRAFT MODELS, Cancer research, 53(17), 1993, pp. 3956-3963
Risultati: 1-10 |